SEARCH

SEARCH BY CITATION

References

  • 1
    Kaufman DW, Kelly JP, Rosenberg L et al. (2002) Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. JAMA, 287, 337.
  • 2
    Everitt DE, Avorn J (1986) Drug prescribing for the elderly. Archives of Internal Medicine, 146, 23932396.
  • 3
    Christchilles EA, Foley DJ, Wallace RB et al. (1992) Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. Journal of Gerontology, 47, 137144.
  • 4
    Arnett RH III, Blank LA, Brown AP et al. (1990) National Health Expenditures 1988. Office of National Cost Estimates. Health Care Financing Review, 11, 141.
  • 5
    Gupta S, Rappaport HM, Bennett LT (1996) Inappropriate drug prescribing and related outcomes for elderly Medicaid beneficiaries residing in nursing homes. Clinical Therapeutics, 18, 183196.
  • 6
    Golden AG, Preston RA, Barnett SD et al. (1999) Inappropriate prescribing in homebound older adults. Journal of the American Geriatrics Society, 47, 948953.
  • 7
    Barry M (2002) Drug Expenditure in Ireland 1991–2001. IMJ, 95, 45.
  • 8
    O'Connor K, O'Mahony D (2003) Drugs and ageing. In: ListonR, MulkerrinEC, eds. Medicine for older patients: cases and practice. Dublin, Ireland: Eireann Healthcare Publications, 205.
  • 9
    Meyer BR (2003) Clinical pharmacology and ageing. In: Grimley EvansJ, Franklin WilliamsT, Lynn BeattieB, MichaelJ-P, WilcockG, eds. Oxford textbook of geriatric medicine, 2nd edn. Oxford: Oxford University Press, 127136.
  • 10
    Woodhouse KW, Ewynne HA (1988) Age related changes in liver size and hepatic blood flow: the influence of drug metabolism in the elderly. Clinical Pharmacokinetics, 15, 328344.
  • 11
    Hunt CM, Westerkam WR, Stave GM et al. (1992) Hepatic cytochrome P-4503A (CYP3A) activity in the elderly. Mechanisms of Ageing and Development, 64, 189.
  • 12
    Hunt CM, Westerkam WR, Stave GM (1992) Effect of age and gender on the activity of human hepatic CYP3A. Biochemical Pharmacology, 44, 275.
  • 13
    Vestal RE, Wood AJJ, Shand DG (1988) Adrenoreceptor status and cardiovascular function in ageing. Journal of Hypertension, 6(Suppl. 1), S59S62.
  • 14
    Vestal RE, Wood AJJ, Shand DG (1979) Reduced beta adrenoceptor sensitivity in the elderly. Clinical Pharmacology and therapeutics, 26, 181186.
  • 15
    Gage BF, Fihn SD, White RH (2000) Management and dosing of warfarin therapy. American Journal of Medicine, 109, 481.
  • 16
    BeersMH, BerkowR eds (2000) Clinical Pharmacology. The Merck manual of geriatrics, 3rd edn. White house Station, NJ: Merck Research Laboratories, 5474.
  • 17
    Holbrook AM, Pareira JA, Labiris R et al. (2005) Systematic overview of warfarin and its drug and food interactions. Archives of Internal Medicine, 165, 1095.
  • 18
    Juurlink DN, Mamdani MM, Kopp A et al. (2004) Drug-induced lithium toxicity in the elderly: a population-based study. Journal of the American Geriatrics Society, 52, 794.
  • 19
    Shorr RI, Ray WA, Daugherty JR et al. (1993) Concurrent use of non-steroidal anti-inflammatory drugs and oral anti-coagulants places elderly persons at high risk for haemorrhagic peptic ulcer disease. Archives of Internal Medicine, 153, 1665.
  • 20
    Battistella M, Mamdani MM, Juurlink DN et al. (2005) Risk of upper gastrointestinal haemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Archives of Internal Medicine, 165, 189.
  • 21
    Juurlink DN, Mamdami M, Kopp A et al. (2003) Drug-drug interactions among elderly patients hospitalised for drug toxicity. JAMA, 289, 1652.
  • 22
    Onder G, Pedone C, Landi F et al. (2002) Adverse drug reactions as a cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). Journal of the American Geriatrics Society, 50, 1962.
  • 23
    Goldberg RM, Mabee J, Chan L, Wong S (1996) Drug-drug and drug-disease interactions in the emergency department: analysis of a high-risk population. American Journal of Emergency Medicine, 14, 447450.
  • 24
    Monane M, Monane S, Semla T (1997) Optimal medication use in elders: key to successful ageing. In: Successful ageing. Western Journal of Medicine, 167, 233237.
  • 25
    Col N, Fanale JE, Kronholm P (1990) The role of medication non-compliance and adverse drug reactions in hospitalisations of the elderly. Archives of Internal Medicine, 150, 841845.
  • 26
    Hanlon JT, Schmader KE, Kornkowski MJ et al. (1997) Adverse drug events in high risk older outpatients. Journal of the American Geriatrics Society, 45, 945948.
  • 27
    Bootman JL, Harrison DL, Cox E (1997) The health care cost of drug related morbidity and mortality in nursing facilities. Archives of Internal Medicine, 157, 20892096.
  • 28
    Bates DW, Cullen DJ, Laird N et al. (1995) Incidence of adverse drug events and potential adverse drug events: implications for prevention. ADE prevention study group. JAMA, 274, 2934.
  • 29
    Bates DW, Leape LL, Petrycki S (1993) Incidence and preventability of adverse drug events in hospitalised adults. Journal of General Internal Medicine, 8, 289294.
  • 30
    Johnson JA, Bootman JL (1997) Drug-related morbidity and mortality and the economic impact of pharmaceutical care. American Journal of Health-System Pharmacy, 54, 554558.
  • 31
    Ray WA, Fought RL, Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. American Journal of Epidemiology, 136, 873883.
  • 32
    Philips DP, Christenfeld N, Glynn LM (1998) Increase in US medication-error deaths between 1983 and 1993. Lancet, 351, 643644.
  • 33
    Lindley CM, Tully MP, Paramsothy V et al. (1992) Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age and Ageing, 21, 294300.
  • 34
    Bates DW (1999) Frequency, consequences and prevention of adverse drug events. Journal of Quality in Clinical Practice, 19, 1317.
  • 35
    Pirmohamed M, James S, Meakin S et al. (2004) Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18 820 patients. BMJ, 329, 15.
  • 36
    Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalised patients: a meta-analysis of prospective studies. JAMA, 279, 1200.
  • 37
    Beard K (1992) Adverse drug reactions as a cause of hospital admissions in the aged. Drugs and Aging, 2, 356367.
  • 38
    Bero LA, Lipton HL, Bird JA (1991) Characterization of geriatric drug-related hospital readmissions. Medical Care, 29, 9891003.
  • 39
    Cooper JW (1999) Adverse drug reaction-related hospitalisations of nursing-facility patients: a 4 year study. Southern Medical Journal, 92, 485490.
  • 40
    Klarin I, Wimo A, Fastbom J (2005) The association of inappropriate drug use with hospitalisation and mortality: a population based study of the very old. Drugs and Aging, 22, 6982.
  • 41
    Beers MH, Ouslander JG, Rollingher I et al. (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. Archives of Internal Medicine, 151, 18251832.
  • 42
    Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Archives of Internal Medicine, 157, 15311536.
  • 43
    Fick DM, Cooper JW, Wade W et al. (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults – results of a US Consensus Panel of experts. Archives of Internal Medicine, 163, 27162724.
  • 44
    Naugler CT, Brymer C, Stolee P, Arcese ZA (2000) Development and validation of an improved prescribing for the elderly tool. The Canadian Journal of Clinical Pharmacology, 7, 103107.
  • 45
    McLeod PJ, Huang AR, Tamblyn RN, Gayton DC (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ, 156, 385391.
  • 46
    Stuck AE, Beers MH, Steiner A et al. (1994) Inappropriate medication use in community residing older persons. Archives of Internal Medicine, 154, 21952200.
  • 47
    Aparasu RR, Mort JR (2000) Inappropriate prescribing for the elderly: Beers criteria-based review. Annals of Pharmacotherapy, 34, 338346.
  • 48
    Wilcox SM, Himmelstein DU, Woolhandler S (1994) Inappropriate drug prescribing for community dwelling elderly. JAMA, 272, 292296.
  • 49
    Zhan C, Sangl J, Bierman AS et al. (2001) Potentially inappropriate medication use in the community-dwelling elderly. Findings from the 1996 Medical Expenditure Panel Survey. JAMA, 286, 28232829.
  • 50
    Chin MH, Wang LC, Jin L et al. (1999) Appropriateness of medication selection for older persons in an urban academic emergency department. Academic Emergency Medicine, 6, 12321242.
  • 51
    Piecoro LT, Browning SR, Prince TS et al. (2000) A database analysis of potentially inappropriate drug use in an elderly Medicaid population. Pharmacotherapy, 20, 221228.
  • 52
    Mort JR, Aparasa RR (2000) Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Archives of Internal Medicine, 160, 28252832.
  • 53
    Meredith SM, Feldman PH, Frey D et al. (2001) Possible medication errors in home healthcare patients. Journal of the American Geriatrics Society, 49, 719724.
  • 54
    Fick DM, Waller JL, Maclean JR et al. (2001) Potentially inappropriate medication use in a Medicare Managed care population: association with higher costs and utilization. Journal of Managed Care Pharmacy, 7, 407413.
  • 55
    Spiker EC, Emptage R, Giannamore MR et al. (2001) Potential adverse drug events in an indigent and homeless geriatric population. Annals of Pharmacotherapy, 35, 11661172.
  • 56
    Hanlon JT, Fillenbaum GG, Schmader KE et al. (2000) Inappropriate drug use among community dwelling elderly. Pharmacotherapy, 20, 575582.
  • 57
    Mott DA, Meed PD (2000) Evaluating prescriptions for the elderly: drug/age criteria as a tool to help community pharmacists. Journal of the American Pharmaceutical Association, 40, 417424.
  • 58
    Liu GG, Chritensen DB (2002) The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. Journal of the American Pharmaceutical Association, 42, 847857.
  • 59
    Giron MS, Wang HX, Bernsten C, Thorslund M, Winbald B, Fastbom J (2001) The appropriateness of drug use in an older nondemented and demented population. Journal of the American Geriatrics Society, 49, 277283.
  • 60
    Pitkala KH, Strandberg TE, Tilvis RS (2002) Inappropriate drug prescribing in home-dwelling elderly patients: a population based survey. Archives of Internal Medicine, 162, 17071712.
  • 61
    Fialova D, Topinkova E, Gambassi G et al. (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA, 293, 13481358.
  • 62
    Van Der Hooft CS, ‘t Jong GW, Dieleman JP et al. (2005) Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria – a population based cohort study. British Journal of Clinical Pharmacology, 60, 21372144.
  • 63
    Thirstrup S, Kampmann JP (2001) Adjustment of Europe's drug regulation to public health needs. Lancet, 358, 1734.
  • 64
    AdamsSR ed. (2002) Unnecessary drugs in the elderly including the psychotropic utilization protocol: a guidebook to OBRA implementation. Interpretative HCFA/OBRA guidelines 483.25 (1) Rev.ed MEDPASS. Lancaster, England: AstraZeneca Pharmaceuticals.
  • 65
    Lau DT, Kasper JD, Potter EB et al. (2005) Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Archives of Internal Medicine, 165, 6874.